Lassen Therapeutics

Biotech · Private

IL-18 inhibitor antibody (LP-168) for inflammatory diseases

lassentx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
13
2 granted · 11 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2756CASTAG BIOSCIENCES, INC.——
2757VAXFORM, LLC——
2758LINNAEUS BIOSCIENCE, INC.——
2759Lassen Therapeutics——
2760ORGANIX, INC.——
2761KOLIBER BIOSCIENCES INC.——
2762VIRTUS THERAPEUTICS CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 13

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.